Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06449365 · ClinicalTrials.gov registry record · Phase 4
Comparison of Intravenous V/S Nasal Atomizer Delivery of Midazolam for Conscious Sedation for No-scalpel Vasectomy
A Phase 4 study, sponsored by University of Tennessee Graduate School of Medicine.
- Completed
- Registry status
- Phase 4
- Development phase
- 35
- Enrollment target
NCT06449365 is a Phase 4 study that has completed, run by University of Tennessee Graduate School of Medicine. The registered enrollment target is 35 participants.
The verdict
NCT06449365, a Phase 4 study, has completed, sponsored by University of Tennessee Graduate School of Medicine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 35 participants
- Enrollment target
Study Summary
Purpose: This study compared administration of midazolam via intravenous route with nasal atomizer route for moderate sedation in an office-based vasectomy clinic.
Interventions
- DEVICE midazolam by nasal atomizer
- DRUG intravenous midazolam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2017-10-22 |
| Est. Completion | 2020-08-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06449365
The ClinicalTrials.gov registry entry for NCT06449365 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Tennessee Graduate School of Medicine, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which midazolam by nasal atomizer is the first listed.
NCT06449365 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06449365 about?
NCT06449365 is a clinical study titled "Comparison of Intravenous V/S Nasal Atomizer Delivery of Midazolam for Conscious Sedation for No-scalpel Vasectomy". Purpose: This study compared administration of midazolam via intravenous route with nasal atomizer route for moderate sedation in an office-based vasectomy clinic.
What is the current status of trial NCT06449365?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 35 participants. The study started on 2017-10-22. Estimated completion is 2020-08-07.
What interventions are being tested in trial NCT06449365?
The interventions under investigation include: midazolam by nasal atomizer (DEVICE), intravenous midazolam (DRUG).
Who is sponsoring clinical trial NCT06449365?
This trial is sponsored by University of Tennessee Graduate School of Medicine, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.